Volume Effect in Peng Block for Total Hip Replacement
Launched by AZIENDA OSPEDALIERO, UNIVERSITARIA PISANA · May 19, 2024
Trial Information
Current as of February 19, 2025
Completed
Keywords
ClinConnect Summary
patients were divided into 3 groups on the basis of the volume of anesthetic given to perform the block. in every patient was assessed the nrs, the side effects, if any, and the need for analgesic drugs in the first 24 hour after surgery
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ASA I, ASA II, ASA III
- • Age≥18
- • Total hip replacement surgery in spinal anesthesia
- • Informed consent
- Exclusion Criteria:
- • ASA IV
- • INR\>1.3
- • platelet values\<100\*10\^3/ml a
- • patients on anticoagulant or antiplatelet therapy
- • general anesthesia for total hip replacement surgery
- • patients on chronic opioid therapy
- • altered sensitivity or motility
- • Patients in chronic opioid therapy
- • Refuse to sign informed consent form
- • Unable to sign informed consent form
- • Know allergies to medication used for analgesia
Trial Officials
manuela nicastro, MD
Study Director
aoupisa
About Azienda Ospedaliero, Universitaria Pisana
Azienda Ospedaliero-Universitaria Pisana is a leading academic hospital and research institution located in Pisa, Italy. Renowned for its commitment to advancing medical science, the organization integrates clinical care with innovative research and education. It focuses on a multidisciplinary approach to healthcare, fostering collaborations between various medical specialties to enhance patient outcomes. The institution is actively involved in numerous clinical trials, aiming to develop and evaluate new therapeutic strategies and interventions, thereby contributing significantly to the global medical community and improving health standards.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pisa, Toscana, Italy
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0